Tag: robot-assisted percutaneous coronary intervention (pci) market growth

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?

The robot-assisted percutaneous coronary intervention (pci) market size has experienced substantial growth in recent years. This market is projected to expand from $27.56 billion in 2025 to $38.73 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 40.5%. Historically, the market’s expansion can be attributed to factors such as an increase in coronary artery disease prevalence, the inherent limitations of manual pci precision, the growing adoption of catheter-based interventions, heightened awareness regarding radiation risks, and the proliferation of cardiac catheterization laboratories.

The robot-assisted percutaneous coronary intervention (pci) market size is projected to experience rapid expansion in the coming years. It will grow to $149.68 billion in 2030 at a compound annual growth rate (CAGR) of 40.2%. This expansion during the projection period stems from progress in robotic-assisted intervention technologies, greater integration of automation within cardiology, increased capital allocation for digital healthcare infrastructure, a surging need for intricate and high-risk PCI procedures, and favorable regulatory endorsements for robotic platforms. Key trends anticipated during the forecast period encompass a growing uptake of minimally invasive cardiac interventions, a heightened emphasis on lowering radiation exposure for medical professionals, a greater call for exactness and accuracy in procedures, an broadening of complex coronary intervention abilities, and enhanced patient safety with improved clinical results.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=86173535&type=smp&name=Robot-Assisted%20Percutaneous%20Coronary%20Intervention%20%28PCI%29%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Industry Drivers: What’s Behind The Revenue Growth?

The robot-assisted percutaneous coronary intervention (PCI) market is projected to expand due to the rising incidence of cardiovascular diseases. These diseases encompass various heart and blood vessel disorders, such as coronary artery disease, heart attacks, and stroke. A primary factor contributing to the increase in cardiovascular ailments is sedentary lifestyles, which can result in obesity, high blood pressure, and diminished heart health. Robot-assisted percutaneous coronary intervention (PCI) offers a solution for cardiovascular diseases by precisely clearing obstructed or constricted coronary arteries, thereby reestablishing blood flow to the heart, minimizing procedural dangers and radiation, and ultimately improving patient results. As an illustration, GOV.UK, a UK government body, stated in December 2024 that by March 2024, approximately 2.24 million adults in England, representing about 4.4% of individuals aged 18 and over, had a GP diagnosis of CKD, marking an increase from 2.09 million cases reported in the preceding year. Consequently, the rising occurrence of cardiovascular diseases is a key factor propelling the expansion of the robot-assisted percutaneous coronary intervention (PCI) market.

Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Breakdown By Product Type And Application

The robot-assisted percutaneous coronary intervention (pci) market covered in this report is segmented –

1) By Component: Robotic Systems, Catheters And Guidewires, Control Consoles

2) By Application: Coronary Angioplasty, Stent Placement, Thrombectomy

3) By End-User: Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Robotic Systems: Electromechanical Robotic Arms, Imaging Integration Units, Robotic Drive Systems

2) By Catheters And Guidewires: Coronary Guidewires, Balloon Catheters, Drug-Eluting Catheters

3) By Control Consoles: Touchscreen Interfaces, Joystick Controllers, Imaging Display Panels

#Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Growth Trends: What’s Shaping The Future Outlook?

Leading companies in the robot-assisted percutaneous coronary intervention (PCI) market are prioritizing the development of sophisticated robotic cardiologist platforms to enhance patient safety and simplify complex coronary interventions. A robotic cardiology platform is an advanced technological system designed to assist cardiologists in performing accurate and controlled coronary procedures, thereby increasing precision, minimizing human error, and reducing radiation exposure for both patients and medical personnel. For example, in May 2023, Robocath SAS, a France-based company specializing in robotic solutions for vascular interventions, introduced the R-One+. This advanced robotic solution allows interventional cardiologists to perform coronary angioplasties (percutaneous coronary intervention, or PCI) by controlling devices through an integrated command unit located in either the catheterization lab or a control room. The R-One+ improves precision in device manipulation, boosts safety for both patients and medical staff by lowering radiation exposure, and provides more comfortable working conditions for operators. The launch was announced at the EuroPCR conference in Paris, where the platform demonstrated new capabilities that make PCI procedures simpler and safer while protecting the cardiology team from radiation-induced injuries. This innovation highlights Robocath’s dedication to enhancing cardiovascular disease treatments with intelligent robotic assistance.

Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Competitive Overview And Top Companies

Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Stereotaxis Inc., Perfint Healthcare, Robocath Inc., Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Philips Healthcare, Terumo Corporation, Asahi Intecc, Catheter Precision, Cardiobot, Remedics, meerecompany Inc., AngioDynamics, Clear Surgical Inc., GE Healthcare, Canon Medical Systems, Asensus Surgical, Endovascular Robotics

View The Full Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Report:

https://thebusinessresearchcompany.com/report/robot-assisted-percutaneous-coronary-intervention-pci-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Top Region: Where Does Most Revenue Come From?

North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (pci) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Expected To Scale Between 2026 And 2030?

The robot-assisted percutaneous coronary intervention (pci) market has experienced substantial expansion in recent years. This market is set to increase from $27.56 billion in 2025 to $38.73 billion in 2026, achieving a compound annual growth rate (CAGR) of 40.5%. The historical growth of this market can be attributed to the rising prevalence of coronary artery disease, the inherent limitations of manual pci precision, the increasing adoption of catheter-based interventions, heightened awareness regarding radiation risks, and the proliferation of cardiac catheterization labs.

The market size for robot-assisted percutaneous coronary intervention (PCI) is anticipated to experience considerable growth in the upcoming years. It is projected to expand to $149.68 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 40.2%. This growth during the forecast period can be attributed to advancements in robotic-assisted intervention technologies, a rising adoption of automation within cardiology, increasing investments in digital healthcare infrastructure, growing demand for complex and high-risk PCI procedures, and supportive regulatory approvals for robotic systems. Significant trends in the forecast period include a rising uptake of minimally invasive cardiac procedures, an increasing focus on reducing radiation exposure for clinicians, a growing demand for precision and procedural accuracy, the expansion of complex coronary intervention capabilities, and improved patient safety and clinical outcomes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/robot-assisted-percutaneous-coronary-intervention-pci-global-market-report

Which Important Drivers Are Guiding The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Growth?

The future expansion of the robot-assisted percutaneous coronary intervention (PCI) market is anticipated to be driven by the rising occurrence of cardiovascular diseases. These conditions involve the heart and blood vessels, encompassing ailments such as coronary artery disease, heart attacks, and stroke. The surge in cardiovascular diseases is largely attributed to inactive lifestyles, which contribute to obesity, hypertension, and poorer heart health. Robot-assisted percutaneous coronary intervention (PCI) addresses cardiovascular diseases by precisely reopening blocked or narrowed coronary arteries to restore blood flow to the heart, while also minimizing procedural risks and radiation exposure, thereby improving patient outcomes. For instance, in December 2024, GOV.UK, a UK-based government agency, reported that in March 2024, nearly 2.24 million adults in England—about 4.4% of those aged 18 and over—had a GP-recorded diagnosis of CKD. This marked an increase from 2.09 million cases the previous year. Consequently, the increasing prevalence of cardiovascular diseases is stimulating the growth of the robot-assisted percutaneous coronary intervention (PCI) market.

Which Segment Categories Are Included In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Segment Analysis?

The robot-assisted percutaneous coronary intervention (pci) market covered in this report is segmented –

1) By Component: Robotic Systems, Catheters And Guidewires, Control Consoles

2) By Application: Coronary Angioplasty, Stent Placement, Thrombectomy

3) By End-User: Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Robotic Systems: Electromechanical Robotic Arms, Imaging Integration Units, Robotic Drive Systems

2) By Catheters And Guidewires: Coronary Guidewires, Balloon Catheters, Drug-Eluting Catheters

3) By Control Consoles: Touchscreen Interfaces, Joystick Controllers, Imaging Display Panels

What Trends Are Influencing The Evolution Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

Leading companies in the robot-assisted percutaneous coronary intervention (PCI) market are concentrating on developing sophisticated robotic cardiologist platforms to improve patient safety and streamline complex coronary interventions. A robotic cardiology platform is a high-tech system that assists cardiologists in performing precise and controlled coronary procedures, enhancing accuracy, minimizing human error, and reducing radiation exposure for both patients and medical personnel. For example, in May 2023, Robocath SAS, a France-based company specializing in robotic solutions for vascular interventions, introduced the R-One+. This advanced robotic solution enables interventional cardiologists to perform coronary angioplasties (percutaneous coronary intervention, or PCI) by manipulating devices through an integrated command unit located either in the catheterization lab or a control room. The R-One+ improves precision in device handling, enhances safety for both patients and medical staff by lowering radiation exposure, and offers more comfortable working conditions for operators. The launch took place at the EuroPCR conference in Paris, where the platform showcased new features designed to make PCI procedures simpler and safer, while also protecting the cardiology team from radiation-induced injuries. This innovation highlights Robocath’s commitment to enhancing cardiovascular disease treatments with intelligent robotic assistance.

Who Are The Active Companies Shaping The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Stereotaxis Inc., Perfint Healthcare, Robocath Inc., Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Philips Healthcare, Terumo Corporation, Asahi Intecc, Catheter Precision, Cardiobot, Remedics, meerecompany Inc., AngioDynamics, Clear Surgical Inc., GE Healthcare, Canon Medical Systems, Asensus Surgical, Endovascular Robotics

Get The Full Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Report:

https://www.thebusinessresearchcompany.com/report/robot-assisted-percutaneous-coronary-intervention-pci-global-market-report

Which Geographic Region Dominates The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (pci) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/robot-assisted-percutaneous-coronary-intervention-pci-global-market-report

Browse Through More Reports Similar to the Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market 2026, By The Business Research Company

Post Consumer Recycled Plastics Market Report 2026

https://www.thebusinessresearchcompany.com/report/post-consumer-recycled-plastics-global-market-report

Plastic Recycling Market Report 2026

https://www.thebusinessresearchcompany.com/report/plastic-recycling-global-market-report

Asphalt Shingles Market Report 2026

https://www.thebusinessresearchcompany.com/report/asphalt-shingles-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market During 2026–2030?

The robot-assisted percutaneous coronary intervention (pci) market has experienced significant expansion in recent years. It is projected to increase from $27.56 billion in 2025 to $38.73 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 40.5%. This historical expansion is linked to factors such as an increase in coronary artery disease prevalence, the inherent limitations of manual pci precision, the growing adoption of catheter-based interventions, a heightened awareness of radiation risks, and the expansion of cardiac catheterization laboratories.

The robot-assisted percutaneous coronary intervention (pci) market is projected to experience rapid expansion over the coming years. This market is anticipated to reach $149.68 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 40.2%. Key drivers for this expansion during the projection period include progress in robotic-assisted intervention technologies, greater embrace of automation within cardiology, increased funding for digital healthcare infrastructure, a surging need for intricate and high-risk pci procedures, and favorable regulatory endorsements for robotic platforms. Significant trends expected in the upcoming period encompass a higher uptake of minimally invasive cardiac interventions, an intensified focus on lowering radiation exposure for medical professionals, a greater requirement for precision and accuracy in procedures, an increase in complex coronary intervention capacities, and enhanced patient safety with better clinical results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27408&type=smp

Which Economic Or Industry Drivers Are Impacting The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

The anticipated expansion of the robot-assisted percutaneous coronary intervention (PCI) market is driven by the rising occurrence of cardiovascular diseases. These conditions encompass a range of heart and blood vessel disorders, such as coronary artery disease, heart attacks, and stroke. A primary contributor to the increase in cardiovascular diseases is inactive lifestyles, which frequently result in obesity, high blood pressure, and compromised heart well-being. Robot-assisted percutaneous coronary intervention (PCI) offers a treatment for cardiovascular diseases by precisely unblocking or widening coronary arteries to reestablish blood flow to the heart, simultaneously minimizing procedural dangers and radiation, and ultimately improving patient results. As an illustration, GOV.UK, a UK government agency, reported in December 2024 that approximately 2.24 million adults in England, representing about 4.4% of individuals aged 18 and over, received a GP diagnosis of CKD in March 2024. This figure marks an increase from 2.09 million cases reported in the preceding year. Consequently, the expanding occurrence of cardiovascular diseases is a key factor propelling the development of the robot-assisted percutaneous coronary intervention (PCI) market.

How Are The Various Segments Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Categorized?

The robot-assisted percutaneous coronary intervention (pci) market covered in this report is segmented –

1) By Component: Robotic Systems, Catheters And Guidewires, Control Consoles

2) By Application: Coronary Angioplasty, Stent Placement, Thrombectomy

3) By End-User: Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Robotic Systems: Electromechanical Robotic Arms, Imaging Integration Units, Robotic Drive Systems

2) By Catheters And Guidewires: Coronary Guidewires, Balloon Catheters, Drug-Eluting Catheters

3) By Control Consoles: Touchscreen Interfaces, Joystick Controllers, Imaging Display Panels

What Trends Are Affecting The Expansion Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

Leading companies operating in the robot-assisted percutaneous coronary intervention (PCI) market are concentrating on developing advanced robotic cardiologist platforms to enhance patient safety and streamline complex coronary interventions. A robotic cardiology platform functions as a high-technology system that assists cardiologists in performing accurate and controlled coronary procedures, thereby boosting precision, minimizing human error, and reducing radiation exposure for patients and medical staff. For example, in May 2023, Robocath SAS, a France-based company specializing in robotic solutions for vascular interventions, introduced the R-One+. This sophisticated robotic solution allows interventional cardiologists to execute coronary angioplasties (percutaneous coronary intervention, or PCI) by managing devices through an integrated command unit located within the catheterization lab or control room. The R-One+ improves precision in device manipulation, enhances safety for both patients and medical staff by decreasing radiation exposure, and offers more comfortable working conditions for operators. The launch was announced at the EuroPCR conference in Paris, where the platform demonstrated new capabilities designed to make PCI procedures simpler and safer while shielding the cardiology team from radiation-induced injuries. This innovation underscores Robocath’s commitment to advancing cardiovascular disease treatments with intelligent robotic assistance.

Which Major Firms Influence Developments In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Stereotaxis Inc., Perfint Healthcare, Robocath Inc., Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Philips Healthcare, Terumo Corporation, Asahi Intecc, Catheter Precision, Cardiobot, Remedics, meerecompany Inc., AngioDynamics, Clear Surgical Inc., GE Healthcare, Canon Medical Systems, Asensus Surgical, Endovascular Robotics

Read the full robot-assisted percutaneous coronary intervention (pci) market report here:

https://www.thebusinessresearchcompany.com/report/robot-assisted-percutaneous-coronary-intervention-pci-global-market-report

What Are The Top-Performing Regions Within The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (pci) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27408&type=smp

Browse Through More Reports Similar to the Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market 2026, By The Business Research Company

Post Consumer Recycled Plastics Market Report 2026

https://www.thebusinessresearchcompany.com/report/post-consumer-recycled-plastics-global-market-report

Plastic Recycling Market Report 2026

https://www.thebusinessresearchcompany.com/report/plastic-recycling-global-market-report

Asphalt Shingles Market Report 2026

https://www.thebusinessresearchcompany.com/report/asphalt-shingles-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Robot-Assisted Percutaneous Coronary Intervention (PCI) Market covering 2026–2035?

The market size for robot-assisted percutaneous coronary intervention (PCI) has shown substantial growth in recent years. This market is forecasted to increase from $27.56 billion in 2025 to $38.73 billion in 2026, achieving a compound annual growth rate (CAGR) of 40.5%. The expansion observed historically can be credited to factors such as the rising prevalence of coronary artery disease, the precision limitations of manual PCI procedures, the increasing application of catheter-based interventions, a greater understanding of radiation risks, and the establishment of more cardiac catheterization labs.

The market for robot-assisted percutaneous coronary intervention (pci) is anticipated to experience substantial expansion in the coming years. By 2030, this market is projected to reach $149.68 billion, advancing at a compound annual growth rate (CAGR) of 40.2%. During the projected period, this expansion is fueled by progress in robotic-assisted intervention techniques, the increased integration of automation within cardiology, greater financial commitments to digital healthcare frameworks, a heightened need for intricate and risky pci operations, and favorable regulatory endorsements for robotic platforms. Significant trends anticipated throughout the forecast period encompass the increasing acceptance of minimally invasive cardiac surgeries, a stronger emphasis on minimizing radiation exposure for medical professionals, a surging requirement for exactness and accuracy in procedures, the broadening of capabilities for complex coronary interventions, and enhanced patient well-being along with better clinical results.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27408&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

The rising occurrence of heart and blood vessel conditions is anticipated to fuel the expansion of the robot-assisted percutaneous coronary intervention (PCI) market moving ahead. These conditions encompass a range of ailments affecting the heart and vascular system, such as coronary artery disease, myocardial infarctions, and cerebrovascular accidents. An increase in cardiovascular diseases is primarily attributed to inactive lifestyles, resulting in weight gain, high blood pressure, and suboptimal cardiac well-being. Robot-assisted percutaneous coronary intervention (PCI) addresses cardiovascular diseases by precisely clearing obstructed or constricted coronary arteries, thereby re-establishing blood circulation to the heart, while minimizing procedural hazards and radiation exposure, leading to improved patient results. For instance, in December 2024, GOV.UK, a UK-based government agency, reported that in March 2024, nearly 2.24 million adults in England—about 4.4% of those aged 18 and over—had a GP-recorded diagnosis of CKD. This reflected an increase from 2.09 million cases the previous year. Consequently, the growing incidence of cardiovascular diseases is propelling the expansion of the robot-assisted percutaneous coronary intervention (PCI) market.

What Segments Are Identified Within The Structure Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

The robot-assisted percutaneous coronary intervention (pci) market covered in this report is segmented –

1) By Component: Robotic Systems, Catheters And Guidewires, Control Consoles

2) By Application: Coronary Angioplasty, Stent Placement, Thrombectomy

3) By End-User: Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Robotic Systems: Electromechanical Robotic Arms, Imaging Integration Units, Robotic Drive Systems

2) By Catheters And Guidewires: Coronary Guidewires, Balloon Catheters, Drug-Eluting Catheters

3) By Control Consoles: Touchscreen Interfaces, Joystick Controllers, Imaging Display Panels

What Trends Are Expected To Impact The Competitive Landscape Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

Leading companies in the robot-assisted percutaneous coronary intervention (PCI) market are concentrating on developing sophisticated robotic cardiologist platforms to enhance patient safety and streamline complex coronary interventions. A robotic cardiology platform is an advanced technological system that assists cardiologists in performing precise and controlled coronary procedures, boosting accuracy, minimizing human error, and reducing radiation exposure for both patients and medical staff. For instance, in May 2023, Robocath SAS, a France-based company specializing in robotic solutions for vascular interventions, launched the R-One+. This advanced robotic solution empowers interventional cardiologists to perform coronary angioplasties (percutaneous coronary intervention, or PCI) by manipulating devices through an integrated command unit located in the catheterization lab or control room. The R-One+ increases precision in device handling, improves safety for patients and medical staff by decreasing radiation exposure, and provides more comfortable working conditions for operators. The launch occurred at the EuroPCR conference in Paris, where the platform demonstrated new capabilities that simplify and secure PCI procedures while protecting the cardiology team from radiation-induced injuries. This innovation highlights Robocath’s dedication to advancing cardiovascular disease treatments with intelligent robotic assistance.

Which Major Firms Are Strengthening Their Position In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Stereotaxis Inc., Perfint Healthcare, Robocath Inc., Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Philips Healthcare, Terumo Corporation, Asahi Intecc, Catheter Precision, Cardiobot, Remedics, meerecompany Inc., AngioDynamics, Clear Surgical Inc., GE Healthcare, Canon Medical Systems, Asensus Surgical, Endovascular Robotics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/robot-assisted-percutaneous-coronary-intervention-pci-global-market-report

Which Regions Are Projected To Dominate The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market In The Coming Years?

North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (pci) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27408&type=smp

Browse Through More Reports Similar to the Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market 2026, By The Business Research Company

Post Consumer Recycled Plastics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/post-consumer-recycled-plastics-global-market-report

Plastic Recycling Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/plastic-recycling-global-market-report

Asphalt Shingles Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/asphalt-shingles-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the robot-assisted percutaneous coronary intervention (pci) market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Be Worth By 2029?

The market size for robot-assisted percutaneous coronary intervention (PCI) has expanded significantly in recent years. It is projected to increase from $19.59 billion in 2024 to $27.56 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 40.7%. This historic expansion can be linked to several factors, such as the increasing number of clinical trials validating robotic percutaneous coronary intervention, enhanced procedural success rates compared to conventional percutaneous coronary intervention, the expansion of physician training programs for robotic systems, a growing patient inclination for innovative treatment approaches, and the increasing availability of reimbursement policies in developed regions.

The robot-assisted percutaneous coronary intervention (PCI) market is projected to experience substantial expansion in the coming years, reaching $106.86 billion by 2029, with a robust compound annual growth rate (CAGR) of 40.3%. This projected growth throughout the forecast period stems from several factors, including the increasing incorporation of 5G and remote real-time operational capabilities, the wider adoption of robotic percutaneous coronary intervention systems within ambulatory surgical centers, an intensified focus on shortening hospital stays following percutaneous coronary intervention, increasing investment from venture capital firms in new robotic cardiology companies, and the greater use of machine learning to assist with procedural guidance and planning. Key trends anticipated during this period involve improvements in cloud-based robotic percutaneous coronary intervention platforms to facilitate real-time data exchange, the implementation of sophisticated cybersecurity measures to safeguard robotic-assisted procedural data, the creation of robotic systems specifically designed for outpatient cardiac care environments, breakthroughs in artificial intelligence-driven robotic learning from procedural information, and the development of smaller robotic instruments for highly precise coronary navigation.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27408&type=smp

What Market Forces Are Contributing To The Growth Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

The escalating incidence of cardiovascular diseases is projected to stimulate the growth of the robot-assisted percutaneous coronary intervention (PCI) market. These conditions, which involve the heart and blood vessels and include issues such as heart attacks and stroke, are becoming more widespread due to sedentary lifestyles contributing to obesity, high blood pressure, and compromised heart health. Robot-assisted percutaneous coronary intervention (PCI) addresses cardiovascular diseases by precisely clearing obstructed or narrowed coronary arteries to restore cardiac blood flow, concurrently reducing procedural dangers and radiation exposure, thereby improving patient outcomes. As an illustration, the American Heart Association stated in January 2024 that high blood pressure was primarily associated with 131,454 deaths in 2022, an increase from 124,508 deaths in 2021. Hence, the increasing prevalence of cardiovascular diseases is a significant factor driving the expansion of the robot-assisted percutaneous coronary intervention (PCI) market.

Which Segments Define The Structure Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

The robot-assisted percutaneous coronary intervention (PCI) market covered in this report is segmented

1) By Component: Robotic Systems, Catheters And Guidewires, Control Consoles

2) By Application: Coronary Angioplasty, Stent Placement, Thrombectomy

3) By End-User: Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Robotic Systems: Electromechanical Robotic Arms, Imaging Integration Units, Robotic Drive Systems

2) By Catheters And Guidewires: Coronary Guidewires, Balloon Catheters, Drug-Eluting Catheters

3) By Control Consoles: Touchscreen Interfaces, Joystick Controllers, Imaging Display Panels

What Strategic Shifts And Innovations Are Influencing The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

Leading companies in the robot-assisted percutaneous coronary intervention (PCI) market are concentrating on developing sophisticated robotic cardiologist platforms to enhance patient safety and streamline intricate coronary interventions. A robotic cardiology platform represents a high-technology system designed to assist cardiologists in executing precise and controlled coronary procedures, thereby boosting accuracy, minimizing human error, and reducing radiation exposure for both patients and medical staff. For instance, in May 2023, Robocath SAS, a France-based firm specializing in robotic solutions for vascular interventions, introduced its R-One+. This advanced robotic solution allows interventional cardiologists to perform coronary angioplasties (percutaneous coronary intervention, or PCI) by operating devices via an integrated command unit situated within the catheterization lab or control room. The R-One+ improves precision in device manipulation, increases safety for both patients and medical personnel by decreasing radiation exposure, and provides more comfortable working environments for operators. The launch took place at the EuroPCR conference in Paris, where the platform exhibited new functionalities aimed at making PCI procedures simpler and safer while protecting the cardiology team from radiation-related injuries. This innovation demonstrates Robocath’s dedication to improving cardiovascular disease treatments using intelligent robotic assistance.

Which Firms Are Making The Biggest Impact In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Medical Microinstruments, Quantum Surgical, Stereotaxis Inc., THINK Surgical Inc., Perfint Healthcare, Robocath Inc., SS Innovations, Auris Health, EP Solutions SA, NDR Medical Technology, Meril Life Sciences Pvt. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/robot-assisted-percutaneous-coronary-intervention-pci-global-market-report

Which Region Is Forecasted To Lead The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market In The Coming Years?

North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (PCI) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27408&type=smp

Browse Through More Reports Similar to the Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market 2025, By The Business Research Company

Recycled Plastics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/recycled-plastics-global-market-report

Plastic Recycling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/plastic-recycling-global-market-report

Asphalt Shingles Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/asphalt-shingles-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Industry By The Forecast Year 2029?

The robot-assisted percutaneous coronary intervention (PCI) market size has witnessed substantial growth in recent years. It is forecast to climb from $19.59 billion in 2024 to $27.56 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 40.7%. The expansion observed during the past period stemmed from factors such as the increasing number of clinical trials validating robotic percutaneous coronary intervention, improved procedural success rates when compared to conventional percutaneous coronary intervention, the growth of physician training programs for robotic systems, a rising patient inclination towards innovative treatment approaches, and the expanding availability of reimbursement policies in developed regions.

The robot-assisted percutaneous coronary intervention (PCI) market is projected to expand significantly in the coming years, reaching $106.86 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 40.3%. This expansion during the forecast period is fueled by factors such as the increasing integration of 5G and remote real-time operation capabilities, the wider deployment of robotic percutaneous coronary intervention systems in ambulatory surgical centers, a heightened emphasis on shortening hospital stays following percutaneous coronary intervention, growing venture capital investment in robotic cardiology startups, and the greater adoption of machine learning for guiding and planning procedures. Key trends anticipated in this period encompass improvements in cloud-based robotic percutaneous coronary intervention platforms to facilitate real-time data sharing, sophisticated cybersecurity protocols to safeguard robotic-assisted procedural data, the creation of robotic systems specifically designed for outpatient cardiac care, advancements in artificial intelligence-driven robotic learning from procedural data, and progress in miniaturized robotic instruments for highly precise coronary navigation.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27408&type=smp

Which Drivers Are Impacting The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

The increasing occurrence of cardiovascular diseases is projected to fuel the expansion of the robot-assisted percutaneous coronary intervention (PCI) market moving forward. These diseases are a category of conditions involving the heart and blood vessels, including issues like coronary artery disease, heart attacks, and stroke. The escalation in cardiovascular diseases is largely attributable to inactive lifestyles, which contribute to obesity, hypertension, and compromised heart health. Robot-assisted percutaneous coronary intervention (PCI) offers a treatment for cardiovascular diseases by accurately re-opening obstructed or narrowed coronary arteries to reinstate blood flow to the heart, while also reducing procedural risks and radiation exposure and enhancing patient outcomes. For instance, data from January 2024, provided by the American Heart Association, a US-based nonprofit organization, indicated that 131,454 deaths were primarily linked to high blood pressure in 2022, an increase from 124,508 deaths in 2021. Consequently, the rising prevalence of cardiovascular diseases is a key driver for the growth of the robot-assisted percutaneous coronary intervention (PCI) market.

What Are The Emerging Segments Gaining Attention In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

The robot-assisted percutaneous coronary intervention (PCI) market covered in this report is segmented

1) By Component: Robotic Systems, Catheters And Guidewires, Control Consoles

2) By Application: Coronary Angioplasty, Stent Placement, Thrombectomy

3) By End-User: Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Robotic Systems: Electromechanical Robotic Arms, Imaging Integration Units, Robotic Drive Systems

2) By Catheters And Guidewires: Coronary Guidewires, Balloon Catheters, Drug-Eluting Catheters

3) By Control Consoles: Touchscreen Interfaces, Joystick Controllers, Imaging Display Panels

How Are Emerging Market Trends Shaping The Robot-Assisted Percutaneous Coronary Intervention (PCI) Industry Landscape?

Leading companies in the robot-assisted percutaneous coronary intervention (PCI) market are focusing on developing advanced robotic cardiologist platforms to enhance patient safety and streamline complex coronary interventions. Such a robotic cardiology platform is a high-tech system designed to assist cardiologists in performing accurate and controlled coronary procedures, thereby improving precision, minimizing human error, and reducing radiation exposure for both patients and medical staff. For example, in May 2023, Robocath SAS, a France-based company specializing in robotic solutions for vascular interventions, introduced its R-One+. This advanced robotic solution enables interventional cardiologists to perform coronary angioplasties (percutaneous coronary intervention, or PCI) by remotely controlling devices through an integrated command unit located within the catheterization lab or a control room. The R-One+ improves precision in device manipulation, boosts safety for both patients and medical staff by lowering radiation exposure, and offers more comfortable working conditions for operators. Its launch took place at the EuroPCR conference in Paris, where the platform showcased new capabilities designed to make PCI procedures easier and safer, while also protecting the cardiology team from radiation-induced injuries. This innovation reflects Robocath’s dedication to advancing cardiovascular disease treatments through smart robotic assistance.

Who Are The Major Companies Operating In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Medical Microinstruments, Quantum Surgical, Stereotaxis Inc., THINK Surgical Inc., Perfint Healthcare, Robocath Inc., SS Innovations, Auris Health, EP Solutions SA, NDR Medical Technology, Meril Life Sciences Pvt. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/robot-assisted-percutaneous-coronary-intervention-pci-global-market-report

Which Regional Markets Are Contributing Most To The Robot-Assisted Percutaneous Coronary Intervention (PCI) Industry Expansion?

North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (PCI) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27408&type=smp

Browse Through More Reports Similar to the Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market 2025, By The Business Research Company

Recycled Plastics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/recycled-plastics-global-market-report

Post Consumer Recycled Plastics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/post-consumer-recycled-plastics-global-market-report

Plastic Recycling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/plastic-recycling-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Expected to Be in 2029?

In recent times, the market size for robot-assisted percutaneous coronary intervention (PCI) has seen significant growth. The market, which stands at $19.59 billion in 2024, is projected to increase to a hefty $27.56 billion in 2025, representing a compound annual growth rate (CAGR) of 40.7%. Factors contributing to this historical growth include an increase in clinical trials validating robotic percutaneous coronary intervention, higher success rates of these procedures compared to traditional interventions, a surge in training programs for doctors on robotic systems, a rising patient preference for advanced treatment methods, and the increasing inclusion of reimbursement policies in more developed regions.

The market for robot-assisted percutaneous coronary intervention (PCI) is forecasted to experience significant growth in the coming years, ballooning to a value of $106.86 billion by 2029, with a compound annual growth rate (CAGR) of 40.3%. This projected growth during the forecast period is due to several factors, including the increasing use of 5G technology and remote operations capabilities in real-time, the expansion of robotic PCI systems in ambulatory surgical centers, the focus on minimizing the hospital stay following PCI, a heightened interest from venture capitalists in robotic cardiology startups, and the elevated use of machine learning in procedural planning and guidance. Future trends anticipated in the forecast period include the progression of cloud-based robotic PCI platforms for immediate data sharing, improved cybersecurity measures for the safeguarding of robot-assisted procedural data, the creation of robotic systems designed specifically for outpatient cardiac care, advancements in AI-driven robotic learning using procedural datasets, and the development of miniaturized robotic instruments for highly accurate coronary navigation.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27408&type=smp

What Are The Contributors To Demand In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?

The surge in cardiovascular ailments is likely to stimulate the expansion of the market for robot-assisted percutaneous coronary intervention (PCI). These diseases encompass various disorders afflicting the heart and blood vessels such as coronary artery disease, stroke, and heart attacks. Sedentary lifestyles are causing an increase in these diseases, leading to issues like obesity, hypertension and poor cardiac health. The robot-assisted percutaneous coronary intervention (PCI) addresses these ailments by adeptly unblocking or dilating constricted coronary arteries, thereby restoring heart’s blood supply while minimizing procedure-associated risks and exposure to radiation, thus improving patient outcomes. As an illustration, data from the American Heart Association, a nonprofit based out of the US, points out that there were 131,454 deaths primarily due to high blood pressure in January 2024, which marks an upturn from the 124,508 deaths recorded in 2021. Consequently, the escalating incidence of cardiovascular diseases is propelling the expansion of the robot-assisted percutaneous coronary intervention (PCI) market.

What Segmentation Categories Are Included In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Analysis?

The robot-assisted percutaneous coronary intervention (PCI) market covered in this report is segmented

1) By Component: Robotic Systems, Catheters And Guidewires, Control Consoles

2) By Application: Coronary Angioplasty, Stent Placement, Thrombectomy

3) By End-User: Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Robotic Systems: Electromechanical Robotic Arms, Imaging Integration Units, Robotic Drive Systems

2) By Catheters And Guidewires: Coronary Guidewires, Balloon Catheters, Drug-Eluting Catheters

3) By Control Consoles: Touchscreen Interfaces, Joystick Controllers, Imaging Display Panels

What Upcoming Trends Are Expected To Impact The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Globally?

Leading businesses in the robot-assisted percutaneous coronary intervention (PCI) market are concentrating on the creation of state-of-the-art robotic cardiology systems, aimed at enhancing patient safety and making complicated coronary procedures more manageable. Robotic cardiology platforms, equipped with high-tech features, assist healthcare professionals in executing precise, controlled coronary interventions. Such platforms help enhance precision, minimize human errors, and reduce radiation exposure to both patients and the medical workforce. For instance, in May 2023, Robocath SAS, a French company known for its expertise in robotic vascular intervention solutions, unveiled the R-One+. This groundbreaking robotic technology empowers interventional cardiologists to carry out coronary angioplasties (percutaneous coronary intervention, or PCI) by controlling the devices via a centralized command unit situated either in the cath lab or control room. The R-One+ boosts the accuracy of device manoeuvres, enhances safety through reduced radiation exposure for patients and medical specialists, and offers more conducive working conditions for operators. Debuted at the EuroPCR conference in Paris, the revolutionary platform showcased never-before-seen capabilities that simplify PCI procedures, and safeguard the cardiac team from injuries due to radiation. This technological advancement exhibits Robocath’s dedication to enhance the treatment of cardiovascular illnesses via intelligent robotic backing.

Who Are The Top-Ranked Companies In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Today?

Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Medical Microinstruments, Quantum Surgical, Stereotaxis Inc., THINK Surgical Inc., Perfint Healthcare, Robocath Inc., SS Innovations, Auris Health, EP Solutions SA, NDR Medical Technology, Meril Life Sciences Pvt. Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/robot-assisted-percutaneous-coronary-intervention-pci-global-market-report

How Is Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (PCI) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=27408&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model